English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine Healthcare & Pharm
Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia
Mar 31, 2023 09:28 HKT
Yunkang Group Announces First Annual Results Since Listing
Mar 31, 2023 07:38 HKT
Ocumension Therapeutics Announces 2022 Annual Results
Mar 30, 2023 22:29 HKT
Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq
Mar 30, 2023 20:29 HKT
Universal Medical (2666.HK) Announces 2022 Annual Results
Mar 29, 2023 19:35 HKT
EuroEyes Delivers Solid Results in 2022
Mar 28, 2023 23:15 HKT
Q'Apel Medical Inc. Granted CE Mark Under MDR for Their Walrus Balloon Guide Catheter
Mar 28, 2023 20:00 HKT
Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
Mar 28, 2023 19:00 HKT
OrbusNeich Plans to Set up Its Largest R&D and Production Base in Fuchun Bay New Town, Hangzhou, the PRC
Mar 28, 2023 17:28 HKT
Sihuan Pharmaceutical (0460.HK) Announces 2022 Annual Results
Mar 24, 2023 19:16 HKT
EC Healthcare Collaborates with New Horizon Health to form Strategic Partnership To Jointly Launch CerviClear in Hong Kong
Mar 24, 2023 17:21 HKT
Health-ISAC Releases Annual Report on Current and Emerging Cyber Threats to Healthcare
Mar 22, 2023 23:00 HKT
With U.S. Health Systems Under Growing Pressure to Fill Staff Vacancies, CGFNS Alliance Releases Updated Standards for Ethical Recruitment of Foreign Health Workers
Mar 21, 2023 19:00 HKT
Singapore family cord blood bank Cryoviva upgrades to AXP II System for cord blood processing
Mar 21, 2023 08:30 HKT
Avantor Named Best Bioprocessing Company in Chromatography at the Asia-Pacific Bioprocessing Excellence Awards
Mar 16, 2023 09:00 HKT
Amazfit Launches GTR Mini in Malaysia
Mar 15, 2023 19:00 HKT
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology
Mar 14, 2023 22:05 HKT
Ocumension Therapeutics Announces Inclusion of Its Shares in the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs
Mar 13, 2023 18:30 HKT
Essex Bio-Technology Announces 2022 Annual Financial Results
Mar 08, 2023 20:28 HKT
OrbusNeich Announces First Annual Results After Listing, Record Revenue of US$136.8 Million, Adjusted Net Profit Up 25% to US$26.7 Million
Mar 08, 2023 18:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: